Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems Awarded US Patent

Premium
Applied Biosystems has been awarded United States Patent 7,428,047, “Time-delay integration in a flow cytometry system.”
 
Mark Oldham, Eric Nordman, Richard Reel, and John Shigeura.
 
The patent provides an apparatus for detecting analytes in a sample. According to the abstract, the apparatus can include: a flow cytometry system comprising one or more detection zones; one or more irradiation sources disposed for irradiating the detection zones; at least one detector disposed for collecting charges corresponding to light signals emitted from detectable analytes in the detection zones, which have been excited by the radiation, wherein at least one detector includes an output; a system coupled to the detector(s) for effecting time-delay integration of the charges by accumulating the charges before reading them at the output of the detector(s); and a sorting mechanism, for example, to effect flow cytometry. The patent also describes methods for detecting analytes in a sample.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.